Enveric Biosciences Inc
Research Enveric Biosciences Inc (ENVB) on Bullrun: market cap USD 2.60M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerENVB
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 2.60M
- Financial periodFY2025
- Net incomeUSD 12.10M
Valuation Snapshot
latest market cap is USD 2.60M.
About Enveric Biosciences Inc
Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications.
Frequently asked questions
What is Enveric Biosciences Inc's market cap?
Enveric Biosciences Inc's market capitalization is USD 2.60M.
What does Enveric Biosciences Inc do?
Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States.